J&J to sell Millennium cancer drug overseas

Johnson & Johnson has reached a deal with Millennium Pharmaceuticals, offering the Cambridge, Mass.-based company up to $750 million to market its cancer drug Velcade overseas. Analysts say Johnson & Johnson is trying to build its cancer drug business.

View Full Article in:

NYTimes.com · Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC